Stage Start Date
Editor in Chief Decision Complete 2nd Nov 21
Manuscript Decision complete 2nd Nov 21
Editor Decision Complete 2nd Nov 21
Under Consideration 1st Nov 21
Editor Assigned 30th Oct 21
Author Approved Converted Files 30th Oct 21
Submission 30th Oct 21

8 1

审稿速度:6.0 | 投稿命中率:25.0 | 影响因子:9.87
偏重的研究方向：肿瘤
经验分享：整体上比较经典的期刊，一篇文章前后修了三次，花了大概半年时间。但是oncogene运营水平一般，没有明显凑热点的操作，且综述发文量不够（相比于cancer letters），明年oncogene影响因子估计在8.5-8.8之间，很难过9分，oncogene影响因子一直波动较大（运营团队未很好操控）相比于cancer letters运营水平明显不行，cancer letters2022年影响因子肯定大概率在9.0-9.8之间。但整体认可度上oncogene还是略高于cancer letters

6 4

审稿速度:2.0 | 投稿命中率:25.0 | 影响因子:9.87
偏重的研究方向：肿瘤学
经验分享：接连被JCI、CCR、CR拒稿后转投Oncogene，3个月大修后居然还有补抗体芯片的小修，历经半年终于accept。感觉Oncogene口碑好是有道理的，editor和reviewer都很严谨，8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77，有点慌，未来几个月冲鸭！🙏 另外求问：oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗？

3 3

请问各位大神，Waiting for Potential Reviewer Assignment 这一步通常持续多长时间啊

3 1

审稿速度:12.0
偏重的研究方向：自噬;肿瘤;干细胞
经验分享：一审
Stage Start Date
Revision Received 1st Jul 21
Waiting for Revision 30th Apr 21
Decision Made 30th Apr 21
Editor in Chief Decision Complete 29th Apr 21
Manuscript Decision complete 29th Apr 21
Editor Decision Complete 29th Apr 21
EIC Decision Started 28th Apr 21
Editor Review Completed 28th Apr 21
All Reviewers Assigned 24th Feb 21
Review Started 16th Feb 21
First Reviewer Accepted 16th Feb 21
Potential Reviewers Accept 16th Feb 21
Contacting Reviewers 16th Feb 21
Reviewers Assigned 16th Feb 21
Waiting for Potential Reviewer Assignment 25th Jan 21
Monitoring Editor Assigned 25th Jan 21
Potential Monitoring Editor Assigned 25th Jan 21
Under Consideration 25th Jan 21
Editor Assigned 23rd Jan 21
Author Approved Converted Files 23rd Jan 21
Submission 22nd Jan 21
大修

二审
Stage Start Date
Revision Received 6th Sep 21
Waiting for Revision 6th Sep 21
Decision Made 6th Sep 21
Editor in Chief Decision Complete 4th Sep 21
Manuscript Decision complete 4th Sep 21
Editor Decision Complete 4th Sep 21
EIC Decision Started 3rd Sep 21
Editor Review Completed 3rd Sep 21
Receiving Editor Review Started 3rd Sep 21
Review Complete 3rd Sep 21
All Reviewers Assigned 18th Jul 21
Review Started 14th Jul 21
First Reviewer Accepted 14th Jul 21
Potential Reviewers Accept 14th Jul 21
Contacting Reviewers 14th Jul 21
Reviewers Assigned 14th Jul 21
Waiting for Potential Reviewer Assignment 5th Jul 21
Monitoring Editor Assigned 5th Jul 21
Potential Monitoring Editor Accept 5th Jul 21
Potential Monitoring Editor Assigned 5th Jul 21
Editor Assigned 1st Jul 21
Author Approved Converted Files 1st Jul 21
Submission 1st Jul 21
小小修，基本不需要改动，当天修回

三审
Stage Start Date
Revision Received 1st Nov 21
Waiting for Revision 1st Nov 21
Decision Made 1st Nov 21
Editor in Chief Decision Complete 31st Oct 21
Manuscript Decision complete 31st Oct 21
Editor Decision Complete 31st Oct 21
EIC Decision Started 30th Oct 21
Editor Review Completed 30th Oct 21
Receiving Editor Review Started 30th Oct 21
Review Complete 30th Oct 21
All Reviewers Assigned 19th Sep 21
Review Started 15th Sep 21
First Reviewer Accepted 15th Sep 21
Potential Reviewers Accept 15th Sep 21
Contacting Reviewers 15th Sep 21
Reviewers Assigned 15th Sep 21
Waiting for Potential Reviewer Assignment 7th Sep 21
Monitoring Editor Assigned 7th Sep 21
Potential Monitoring Editor Accept 7th Sep 21
Potential Monitoring Editor Assigned 7th Sep 21
Editor Assigned 6th Sep 21
Author Approved Converted Files 6th Sep 21
Submission 6th Sep 21
原则接受，等待提交终稿

四审
Stage Start Date
Decision Made 4th Nov 21
Editor in Chief Decision Complete 4th Nov 21
Manuscript Decision complete 4th Nov 21
Editor Decision Complete 4th Nov 21
Waiting for Potential Reviewer Assignment 4th Nov 21
Monitoring Editor Assigned 4th Nov 21
Potential Monitoring Editor Accept 4th Nov 21
Potential Monitoring Editor Assigned 4th Nov 21
Editor Assigned 1st Nov 21
Author Approved Converted Files 1st Nov 21
Submission 1st Nov 21
最终接收
目前等待proof中，投稿到接收耗时9个多月，oncogene是我拿这篇论文投的第一个目标杂志，运气不错，能够直接送审并最终接收。

8 2

审稿速度:1.0
偏重的研究方向：肿瘤学
经验分享：上个月中旬投稿的，一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见，而且还是很友好的的，提出小休后发表。但是主编直接说不合适拒了。哎

12 3

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：今天收到 修回：
Waiting for Revision 30th Nov 20
Decision Made 30th Nov 20
Editor in Chief Decision Complete 27th Nov 20
Manuscript Decision complete 27th Nov 20
Editor Decision Complete 27th Nov 20
EIC Decision Started 27th Nov 20
Editor Review Completed 27th Nov 20
Receiving Editor Review Started 20th Nov 20
Review Complete 20th Nov 20
All Reviewers Assigned 1st Nov 20
Review Started 22nd Oct 20
Under Consdieration 10th Oct 20
Contacting Reviewers 1st Oct 20
Reviewers Assigned 1st Oct 20
Waiting for Potential Reviewer Assignment 30th Sep 20
Monitoring Editor Assigned 30th Sep 20
Potential Monitoring Editor Assigned 30th Sep 20
Under Consideration 30th Sep 20
Editor Assigned 27th Sep 20
Author Approved Converted Files 27th Sep 20
Submission 27th Sep 20

33 1

偏重的研究方向： Molecular cancer ; Oncology
经验分享：二月中旬投稿，七月中旬最终接收，三个审稿人，两次审稿，数据量比较大，不歧视小单位令人好评，国内好点的期刊投稿被要求注明来自哪个大团队，我们这些没山头的青年博士一投稿就被拒，审都不让审，关键是期刊里边同类型的文章有的也还不如我，sad

151 1

请问这个是被拒吗
Stage Start Date
Editor in Chief Decision Complete 2nd Nov 21
Manuscript Decision complete 2nd Nov 21
Editor Decision Complete 2nd Nov 21
Under Consideration 1st Nov 21
Editor Assigned 30th Oct 21
Author Approved Converted Files 30th Oct 21
Submission 30th Oct 21

5 1

oncogene最近居然有好几篇生信文章出来了，不知道是个啥信号

8 0